DnB Asset Management
BIO icon

DnB Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

DnB Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Hold
1,229
– – ﹤0.01% 937
2026
Q1 		$343K Buy
+1,229
New +$354K ﹤0.01% 910
2025
Q2 		– Sell
-3,661
Closed -$892K – 728
2025
Q1 		$892K Buy
3,661
+221
+6% +$66.5K ﹤0.01% 633
2024
Q4 		$1.13M Buy
3,440
+279
+9% +$94.7K ﹤0.01% 634
2024
Q3 		$1.06M Sell
3,161
-258
-8% -$81.9K ﹤0.01% 629
2024
Q2 		$934K Buy
3,419
+258
+8% +$75K ﹤0.01% 628
2024
Q1 		$1.09M Buy
+3,161
New +$1.04M 0.01% 619

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DnB Asset Management's BIO Position: Q2 2026 in Review

DnB Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 1,229 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

DnB Asset Management first reported a position in BIO in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q4 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • DnB Asset Management held 1,229 shares of Bio-Rad Laboratories Class A worth $361K as of Q2 2026.
  • DnB Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #937 holding.
  • DnB Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and has held it in 7 quarters since.
  • DnB Asset Management's Bio-Rad Laboratories Class A position peaked at $1.13M in Q4 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.